Cyclooxygenase-2–derived lipoxin A4 increases gastric resistance to aspirin-induced damage

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Claire Bombardier, Loren Laine, Alise Reicin et al. · New England Journal of Medicine · 2000 · 4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis

Fred E. Silverstein, Gerald A. Faich, Jay L. Goldstein et al. · JAMA · 2000 · 3.2K citations

Medicine, Pharmacology, Pharmacotherapy +16

Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors:  Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)

Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw et al. · Journal of Medicinal Chemistry · 1997 · 2K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

Byron Cryer, Mark Feldman · The American Journal of Medicine · 1998 · 766 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

John L. Wallace, Webb McKnight, Brian K. Reuter et al. · Gastroenterology · 2000 · 706 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14